Oklo (NYSE:OKLO) Price Target Lowered to $73.50 at Citigroup

Oklo (NYSE:OKLO) had its price objective trimmed by Citigroup from $95.00 to $73.50 in a research report report published on Wednesday,Benzinga reports. They currently have a neutral rating on the stock.

Other equities analysts also recently issued research reports about the company. UBS Group restated a “neutral” rating on shares of Oklo in a research report on Monday, January 12th. The Goldman Sachs Group reiterated a “neutral” rating and set a $106.00 price objective on shares of Oklo in a research note on Friday, January 9th. Weiss Ratings reissued a “sell (d)” rating on shares of Oklo in a report on Thursday, January 22nd. Canaccord Genuity Group reduced their target price on shares of Oklo from $175.00 to $125.00 and set a “buy” rating on the stock in a research note on Wednesday. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $90.00 target price on shares of Oklo in a report on Wednesday. Two analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating, five have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $86.63.

Oklo Stock Down 6.2%

Shares of OKLO opened at $56.75 on Wednesday. The company has a 50-day moving average price of $74.26 and a two-hundred day moving average price of $95.00. The stock has a market cap of $8.87 billion, a price-to-earnings ratio of -78.82 and a beta of 0.80. Oklo has a 12 month low of $17.42 and a 12 month high of $193.84.

Oklo (NYSE:OKLO) last released its quarterly earnings data on Tuesday, March 17th. The company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.17) by ($0.10). During the same quarter in the prior year, the company posted ($0.74) earnings per share. Equities research analysts expect that Oklo will post -8.2 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CEO Jacob Dewitte sold 72,960 shares of the stock in a transaction that occurred on Friday, March 13th. The shares were sold at an average price of $60.00, for a total value of $4,377,600.00. Following the transaction, the chief executive officer directly owned 751,533 shares in the company, valued at $45,091,980. This represents a 8.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider William Carroll Murphy Goodwin sold 2,820 shares of the company’s stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $56.69, for a total value of $159,865.80. Following the completion of the sale, the insider owned 15,991 shares of the company’s stock, valued at $906,529.79. This represents a 14.99% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 2,062,424 shares of company stock valued at $169,888,312 over the last ninety days. Insiders own 18.90% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of OKLO. Royal Bank of Canada increased its stake in Oklo by 162.6% in the 1st quarter. Royal Bank of Canada now owns 92,850 shares of the company’s stock valued at $2,009,000 after buying an additional 57,497 shares during the last quarter. AQR Capital Management LLC bought a new position in Oklo during the 1st quarter worth $519,000. Millennium Management LLC raised its stake in Oklo by 4,974.1% in the 1st quarter. Millennium Management LLC now owns 582,002 shares of the company’s stock worth $12,589,000 after purchasing an additional 570,532 shares in the last quarter. NewEdge Advisors LLC boosted its stake in shares of Oklo by 165.6% in the first quarter. NewEdge Advisors LLC now owns 15,672 shares of the company’s stock valued at $339,000 after buying an additional 9,772 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Oklo by 90.9% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 112,772 shares of the company’s stock valued at $2,439,000 after acquiring an additional 53,703 shares during the period. 85.03% of the stock is currently owned by institutional investors.

More Oklo News

Here are the key news stories impacting Oklo this week:

• Positive Sentiment: Oklo secured multiple federal approvals that materially de‑risk commercialization pathways — including DOE Nuclear Safety Design Agreement(s) tied to its Aurora reactor and Groves isotopes test reactor, which accelerate project execution and isotope production potential. BusinessWire: DOE NSDA approval
• Positive Sentiment: Oklo’s Atomic Alchemy unit won a first-of-its-kind NRC materials license for isotope work — opening an early revenue channel (isotope processing/supply) that shortens the timeline to meaningful commercial receipts versus waiting for full reactor deployments. Yahoo: NRC license for Atomic Alchemy
• Neutral Sentiment: High‑profile media exposure — including a CNBC interview with CEO Jacob DeWitte — is increasing investor awareness and liquidity but is not by itself a fundamental catalyst. CNBC CEO interview
• Neutral Sentiment: Strategic partnerships (Meta power‑campus plans, talks with Centrus on HALEU fuel services) underpin the long‑term growth story but remain execution‑dependent and will take quarters to materially affect revenue. Yahoo: Meta deal & valuation check
• Negative Sentiment: Q4 earnings missed expectations — Oklo reported EPS of ($0.27) vs. consensus ($0.17) and remains pre‑revenue; the miss raises short‑term scrutiny on cash burn and timing of commercial revenue. ProactiveInvestors: Q4 results
• Negative Sentiment: Several sell‑side firms trimmed price targets this morning (Goldman Sachs to $65 neutral; Citigroup to $73.50 neutral; Needham, others lowered targets), increasing downward pressure despite some remaining buy ratings. Many of the revisions were published via Benzinga/TickerReport. Benzinga: analyst target moves
• Negative Sentiment: Insider selling from senior executives (CEO and CFO sold sizable blocks in mid‑March) is attracting negative attention and likely added supply into the market today, compounding selling from analyst cuts. Blockonomi: insiders offload

Oklo Company Profile

Oklo, Inc is a California-based energy technology company specializing in the design and development of advanced nuclear microreactors. Headquartered in Fremont, the firm focuses on small modular reactor (SMR) technology that leverages fast-neutron fission and liquid-metal cooling to deliver carbon-free power. Oklo’s core objective is to bring compact, factory-built reactors online within a decade, offering a low-footprint alternative to traditional large nuclear plants.

The company’s flagship product, the Aurora microreactor, is a 1.5-megawatt electric (MWe) fast reactor cooled by a sodium alloy.